Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
Étude OAsIs: étude de phase 1-2, en escalade de dose, évaluant la tolérance d’un traitement associant l’obinutuzumab, venetoclax (GDC-0199) et ibrutinib, chez des patients ayant un lymphome du manteau réfractaire ou en rechute https://www.kusajili.fr:443/Trial/VXk2hH2XR0OXHfrVH-MO6A%24etude-oasis-etude-de-phase-1-2-en-escalade-de-dose-evaluant-la-tolerance-dun-traitement-associant-lobinutuzumab-venetoclax-gdc-
I have read and accept the terms of use of the site and the Privacy Policy
Send your message